MetaADEDB 2.0 @ LMMD
Palonosetron
(OLDRWYVIKMSFFB-SSPJITILSA-N)
Structure
SMILES
O=C1N(C[C@@H]2c3c1cccc3CCC2)[C@@H]1CN2CCC1CC2.Cl
Molecular Formula:
C19H25ClN2O
Molecular Weight:
332.868
Log P:
3.3343
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
23.55
CAS Number(s):
135729-62-3
Synonym(s)
1.
Palonosetron
2.
2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one
3.
2-QHBIQO
4.
Aloxi
5.
Palonosetron Hydrochloride
6.
Palonosetron, (3R)-
7.
Palonosetron, (R-(R*,R*))-isomer
8.
Palonosetron, (R-(R*,S*))-isomer
9.
Palonosetron, (S-(R*,S*))-isomer
10.
RS 25233-197
11.
RS 25233-198
12.
RS 25259
13.
RS 25259-197
14.
RS 25259-198
15.
RS-25233-197
16.
RS-25233-198
17.
RS-25259
18.
RS-25259-197
19.
RS-25259-198
20.
RS 25233 197
21.
RS 25233 198
22.
RS 25233197
23.
RS 25233198
24.
RS 25259 197
25.
RS 25259 198
26.
RS 25259197
27.
RS 25259198
28.
RS25233197
29.
RS25233198
30.
RS25259
31.
RS25259197
32.
RS25259198
External Link(s)
MeSHD000077924
PubChem Compound139071528
6918303
ChEBI85157
CHEMBLCHEMBL1720
KEGGdr:D05343
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product contamination microbialFAERS: 12US FAERS
2Product counterfeitFAERS: 10US FAERS
3NauseaFAERS: 8US FAERS
4Transmission of an infectious agent via productFAERS: 8US FAERS
5HeadacheFAERS: 7US FAERS
6BradycardiaFAERS: 4US FAERS
7Burkholderia cepacia complex infectionFAERS: 4US FAERS
8Exposure to unspecified agentFAERS: 4US FAERS
9Back PainFAERS: 3US FAERS
10Burkholderia cepacia complex sepsisFAERS: 3US FAERS
11Counterfeit drug administeredFAERS: 3US FAERS
12SepsisFAERS: 3US FAERS
13SyncopeFAERS: 3US FAERS
14VomitingFAERS: 3US FAERS
15HypersensitivityFAERS: 2US FAERS
16HypotensionFAERS: 2US FAERS
17RestlessnessFAERS: 2US FAERS
18Suspected counterfeit productFAERS: 2US FAERS
19AlopeciaFAERS: 1US FAERS
20Anaphylactic shockFAERS: 1US FAERS
21ArthralgiaFAERS: 1US FAERS
22AstheniaFAERS: 1US FAERS
23BlepharospasmFAERS: 1US FAERS
24Blood sodium decreasedFAERS: 1US FAERS
25Bone painFAERS: 1US FAERS
26BronchospasmFAERS: 1US FAERS
27Burkholderia test positiveFAERS: 1US FAERS
28Cardiac ArrestFAERS: 1US FAERS
29ChillsFAERS: 1US FAERS
30ConstipationFAERS: 1US FAERS
31DehydrationFAERS: 1US FAERS
32Disease ProgressionFAERS: 1US FAERS
33Drug ineffectiveFAERS: 1US FAERS
34DysphoniaFAERS: 1US FAERS
35Emotional disorderFAERS: 1US FAERS
36ErythemaFAERS: 1US FAERS
37ExtravasationFAERS: 1US FAERS
38Feeling abnormalFAERS: 1US FAERS
39Feeling of body temperature changeFAERS: 1US FAERS
40FlushingFAERS: 1US FAERS
41FolliculitisFAERS: 1US FAERS
42HemiparesisFAERS: 1US FAERS
43Infusion site swellingFAERS: 1US FAERS
44Infusion site urticariaFAERS: 1US FAERS
45Injection site burningFAERS: 1US FAERS
46Injection site extravasationFAERS: 1US FAERS
47Injection site painFAERS: 1US FAERS
48Malignant neoplasm progressionFAERS: 1US FAERS
49MyalgiaFAERS: 1US FAERS
50Neck PainFAERS: 1US FAERS
51PO2 decreasedFAERS: 1US FAERS
52PneumoniaFAERS: 1US FAERS
53Procedural complicationFAERS: 1US FAERS
54Product label counterfeitFAERS: 1US FAERS
55Product packaging counterfeitFAERS: 1US FAERS
56Rash erythematousFAERS: 1US FAERS
57Respiratory arrestFAERS: 1US FAERS
58SomnolenceFAERS: 1US FAERS
59ThrombosisFAERS: 1US FAERS
60UrticariaFAERS: 1US FAERS
61Visual ImpairmentFAERS: 1US FAERS
62Vitreous floatersFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.